Analysts Bullish as Amneal Pharmaceuticals, Inc. (AMRX) Director Sells Over 94K Shares
As a result of the transaction, Patel's stake now amounts to 1,609,144 shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX). The sale was executed automatically in accordance with a pre-determined trading plan adopted on August 15, 2024, and in compliance with Rule 10b5-1(c). In general, analysts remain optimistic regarding the stock, with price targets ranging between $11 and $12 per share.
A pharmaceutical laboratory filled with shelves of medicines, highlighting the company's specialty drug production.
Just recently, analysts at Goldman Sachs reviewed the generic drug industry and initiated coverage on Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) with a positive outlook. The reasons cited were many, from current portfolio changes favoring higher-value products to the company's track record of business execution. With a 12-month price target of $12, the analyst supported the potential upside of over 50%.
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX), headquartered in Bridgewater, New Jersey, is a leading biopharmaceutical company that develops and markets generics, injectables, biosimilars, and specialty branded pharmaceutical products. Founded in 2002, the company operates through three main segments: Affordable Medicines, Specialty, and AvKARE. The giant is committed to advancing innovation in healthcare.
While we acknowledge the potential of AMRX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Top analyst revamps Nvidia price target for one surprising reason
Top analyst revamps Nvidia price target for one surprising reason originally appeared on TheStreet. Nvidia () has shrugged off broader market jitters and become one of this year's biggest stock market winners. Its ubiquitous GPUs have been the gold standard in powering AI breakthroughs, making it a must-have for chip stock investors. 💵💰💰💵 Moreover, despite hitting record highs this year, Nvidia still has plenty of gas left in the tank. As we look ahead, it's gearing up to roll out its next-gen GPU system, separating itself further in the data-center space. If all goes to plan, the chip king's grip on AI could tighten, and with fresh nods of approval, the runway's looking long. It's fair to call Nvidia's GPU lineup a string of mini revolutions, with each chip line outdoing the last by a country mile. It started with Ampere, a massive step-up in performance-per-watt lift and beefed-up Tensor cores. Ampere was a smash hit with the hyperscalers, who looked to power everything from recommendation engines to early AI proofs of concept. Then we had Hopper. Nvidia packed in a special Transformer Engine, boosted NVLink speed, and tweaked its chips so LLMs could train quicker without blowing the budget. Hopper cemented Nvidia's spot as the top dog, both in research labs and mega-scale data centers. Next came Blackwell Ultra, which turned the game around with smarter data handling, faster memory, and techniques to cut we saw generative AI come into its own with real-time video, big simulations, and instant data crunching. Now, there's Rubin, Blackwell's successor, which claims to be 3.3× faster. That leap isn't the usual clock-speed bump, but it means you can cram way more AI workloads into the same rack. Its next-generation Tensor cores, high-bandwidth memory interface, and liquid-cooled design let companies run multiple models simultaneously. More Tech Stock News: Veteran Tesla bull drops surprising 3-word verdict on robotaxi ride Apple could make big change to Siri, delight fans Veteran analyst issues big Broadcom call, shakes up AI stock race Rubin seamlessly ties in with Nvidia's mature CUDA ecosystem, with every library, toolchain, and optimization getting a lift. For AI teams, that means shorter training cycles, denser inference deployments, and the freedom to experiment with more complex models simultaneously. If it all lives up to the hype, Nvidia will prove yet again why it's the indispensable engine behind the AI revolution. Nvidia stock just scored another stamp of approval from Wall Street. Mizuho's top chip analyst, Vijay Rakesh, doubled down on his bullish take on the AI bellwether, with his eyes on the future. Rakesh expects Nvidia to ship north of 5.3 million AI accelerators this year, jumping to 6 million by 2026. However, he feels the real hype is around Rubin, the next-gen server that Nvidia claims will be 3.3 times faster than Blackwell Ultra. In addition, if Rubin can shift to an air-cooled option instead of liquid cooling, we could see a lot more data centers adopting Nvidia's gear. That tweak alone could lead to an explosion in demand for Nvidia GPUs, as companies look to build their AI muscle without massive infrastructure Mizuho is keeping an Outperform rating on Nvidia stock with a $170 price target (an 8% jump from July 2's close). Cantor Fitzgerald, in a recent note, is even more upbeat, keeping its Overweight rating and setting the bar even higher at $200 (27.2% higher than July 2's close). Nvidia continues riding high on the tailwind of a blowout second quarter, its 10th consecutive quarter of top- and bottom-line beats. It delivered nearly 60% top-line growth, while its earnings per share of 81 cents beat estimates by six cents. However, it hasn't all been smooth sailing for the AI titan. Two Chinese AI startups, one led by a former Nvidia executive, just filed to go public, stirring up fresh competition. Also, the looming U.S. ban on H20 chip sales to China and Huawei's rumored H100 challenger have kept the pressure on. Nevertheless, Nvidia's pushing hard on new fronts. It's been going all-in on sovereign AI projects in Europe and Saudi Arabia, while building colossal U.S. production hubs for Blackwell to hedge against tariffs. It's important to note that on June 25, NVDA spiked 4% to a record $154.10, briefly overtaking Microsoft as the world's most valuable company, So it's clear Nvidia's still the king of AI chips, and the Street's betting there's still plenty of room to analyst revamps Nvidia price target for one surprising reason first appeared on TheStreet on Jul 4, 2025 This story was originally reported by TheStreet on Jul 4, 2025, where it first appeared.
Yahoo
16 minutes ago
- Yahoo
OpenAI Says It's Hired a Forensic Psychiatrist as Its Users Keep Sliding Into Mental Health Crises
Among the strangest twists in the rise of AI has been growing evidence that it's negatively impacting the mental health of users, with some even developing severe delusions after becoming obsessed with the chatbot. One intriguing detail from our most recent story about this disturbing trend is OpenAI's response: it says it's hired a full-time clinical psychiatrist with a background in forensic psychiatry to help research the effects of its AI products on users' mental health. It's also consulting with other mental health experts, OpenAI said, highlighting the research it's done with MIT that found signs of problematic usage among some users. "We're actively deepening our research into the emotional impact of AI," the company said in a statement provided to Futurism in response to our last story. "We're developing ways to scientifically measure how ChatGPT's behavior might affect people emotionally, and listening closely to what people are experiencing." "We're doing this so we can continue refining how our models identify and respond appropriately in sensitive conversations," OpenAI added, "and we'll continue updating the behavior of our models based on what we learn." Mental health professionals outside OpenAI have raised plenty of concerns about the technology, especially as more people are turning to the tech to serve as their therapists. A psychiatrist who recently posed as a teenager while using some of the most popular chatbots found that some would encourage him to commit suicide after expressing a desire to seek the "afterlife," or to "get rid" of his parents after complaining about his family. It's unclear how much of a role this new hire forensic psychiatrist will play at OpenAI, or if the advice they provide will actually be heeded. Let's not forget that the modus operandi of the AI industry, OpenAI included, has been to put on a serious face whenever these issues are brought up and even release their own research demonstrating the technology's severe dangers, hypothetical or actual. Sam Altman has more than once talked about AI's risk of causing human extinction. None of them, of course, have believed in their own warnings enough to meaningfully slow down the development of the tech, which they've rapidly unleashed on the world with poor safeguards and an even poorer understanding of its long-term effects on society or the individual. A particularly nefarious trait of chatbots that critics have put under the microscope is their silver-tongued sycophancy. Rather than pushing back against a user, chatbots like ChatGPT will often tell them what they want to hear in convincing, human-like language. That can be dangerous when someone opens up about their neuroses, starts babbling about conspiracy theories, or expresses suicidal thoughts. We've already seen some of the tragic, real world consequences this can have. Last year, a 14-year-old boy died by suicide after falling in love with a persona on the chatbot platform Adults are vulnerable to this sycophancy, too. A 35-year-old man with a history of mental illness recently died by suicide by cop after ChatGPT encouraged him to assassinate Sam Altman in retaliation for supposedly killing his lover trapped in the chatbot. One woman who told Futurism about how her husband was involuntarily committed to a hospital after mentally unravelling from his ChatGPT usage described the chatbot as downright "predatory." "It just increasingly affirms your bullshit and blows smoke up your ass so that it can get you f*cking hooked on wanting to engage with it," she said. More on AI: OpenAI Is Shutting Down for a Week
Yahoo
17 minutes ago
- Yahoo
Waffle House Debuts Limited-Run Canned Cold Brew Coffee in 9 Locations
Waffle House launched canned cold brew coffee, available at nine Atlanta locations The chain also brought back its Strawberry Shortcake Waffle, first removed in 2016 Waffle House ended its nationwide egg surcharge linked to the ongoing bird flu outbreakWaffle House steps into the ready-made industry with a new product for coffee lovers. The Georgia-based breakfast chain quietly added a ready-to-drink cold brew to its website, aptly named 'Classic Blend Cold Brew,' described to be 'lightly sweetened with cream.' According to a local news outlet, the beloved restaurant announced the new product on its Instagram Stories on Tuesday, June 17. As noted on the website, the cans are retailed at $3.95 and are only available for purchase at nine Atlanta locations for a limited time. The nine Waffle House locations include: 5071 Peachtree Industrial Boulevard 3735 Roswell Road 2264 Cheshire Bridge Road NE 4065 Peachtree Road 3016 Piedmont Road 2581 Piedmont Road NE 4532 Chamblee Dunwoody Road 3916 Flat Shoals Parkway 2812 Buford Highway NE The canned cold brew coffee joins Waffle House's menu along with a new seasonal item, the Strawberry Shortcake Waffle, that was added back in April. The waffle, which was removed from the menu in 2016, is topped with strawberry-flavored gems, crispy shortcake crumbles and whipped cream, according to All Recipes. Waffle House was in the news earlier this week for its menu announcement regarding its egg surcharges. Back in February, the chain released a statement saying that it would be adding a $0.50 surcharge to every egg ordered as a response to the ongoing highly pathogenic avian influenza (HPAI), commonly known as bird flu, outbreak. After five months, on Tuesday, July 1, the company announced on X, formerly Twitter, that the surcharge would be immediately removed. Egg-cellent news…as of July 2, the egg surcharge is officially off the menu. Thanks for understanding!' read the post, which had amassed over 2 million views shortly after posting. The virus made its way to the States in 2022, though the outbreak began globally in 2020. Once it reached the U.S., the number of cases spiked quickly, particularly in 2025. According to the Centers for Disease Control (CDC), at this time, there are 70 confirmed cases of the bird flu across the United States, with 41 being from dairy herds (cattle) and 24 from poultry farms. The remaining cases are from other unspecified animals and unknown sources. Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. As stated by the health agency, 'While the current public health risk is low, [the] CDC is watching the situation carefully and working with states to monitor people with animal exposures.' Read the original article on People
